The level of manganese superoxide dismutase content is an independent prognostic factor for glioblastoma. Biological mechanisms and clinical implications.

Ria, F; Landriscina, M; Remiddi, F; Rosselli, R; Iacoangeli, M; Scerrati, M; Pani, G; Borrello, S; Galeotti, T

Ria, F; Landriscina, M; Remiddi, F; Rosselli, R; Iacoangeli, M; Scerrati, M; Pani, G; Borrello, S; Galeotti, T.

Affiliation

Ria F; Institute of General Pathology, Catholic University, Rome, Italy.

Br J Cancer ; 84(4): 529-34, 2001 Feb.

Article in En | MEDLINE | ID: mdl-11207049

Subject(s)

Astrocytoma/enzymology; Biomarkers, Tumor/analysis; Brain Neoplasms/enzymology; Glioblastoma/enzymology; Superoxide Dismutase/analysis; Adult; Aged; Astrocytoma/pathology; Brain Neoplasms/pathology; Female; Follow-Up Studies; Genes, p53/genetics; Glioblastoma/pathology; Humans; Male; Middle Aged; Neoplasm Staging/methods; Prognosis; Survival Analysis

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Astrocytoma / Superoxide Dismutase / Brain Neoplasms / Biomarkers, Tumor / Glioblastoma Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Br J Cancer Year: 2001 Document type: Article Affiliation country: Italy Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google